“…Furthermore, machine perfusion driven viability assessment during HMP/HOPE or NMP may support clinical decision in the acceptance or rejection of marginal liver allografts [ 4 , 6 , 184 ]. Besides refinement of the preservation techniques, the impact of hepatic dysfunction on macro- and micro-rheological parameters still need to be investigated, including metabolomics studies, to reveal better the local and systemic effects [ 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 ]. However, it would be interesting to overview it in a separate paper.…”